January 3, 2017 Lab Top-10 PR/Corporate

Agilent Technologies to Present at Goldman Sach’s Healthcare CEO Conference

SANTA CLARA, Calif.–(BUSINESS WIRE)–Jan. 3, 2017– Agilent Technologies Inc. (NYSE: A) today announced the following webcast for the investment community: Healthcare CEOs Unscripted: A View from the TopInterContinental Hotel BostonThursday, Jan. 5, 2017, at 1 p.m. (ET)Mike McMullen, Agilent president and chief executive officer A link to the webcast will be available at www.investor.agilent.com. About Agilent TechnologiesAgilent Technologies Inc. (NYSE: A), a global... Read more

January 3, 2017 Lab Top-10 PR/Corporate Uncategorized

Agilent Technologies to Present at 35th Annual J.P. Morgan Healthcare Conference

SANTA CLARA, Calif.–(BUSINESS WIRE)–Jan. 3, 2017– Agilent Technologies Inc. (NYSE: A) today announced the following webcast for the investment community: 35thAnnual J.P. Morgan Healthcare ConferenceWestin St. Francis Hotel, San Francisco, CaliforniaTuesday, Jan. 10, 2017, at 3:00 p.m. PTMike McMullen, Agilent president and chief executive officer A link to the webcast will be available at www.investor.agilent.com.... Read more

December 20, 2016 Clinical Research/Diagn. Lab Top-10 Licensing, IP, and Legal M&A, Partnerships Uncategorized

Agilent Technologies to Acquire Multiplicom N.V., a Leading European Diagnostics Company with State-of-the-Art Genetic Testing Technology and Products

Agilent fortifies its target-enrichment portfolio through its planned acquisition of Multiplicom N.V. SANTA CLARA, Calif. & NIEL, Belgium–(BUSINESS WIRE)–Dec. 20, 2016– Agilent Technologies Inc. (NYSE:A) and Multiplicom N.V. today announced that they have signed a definitive agreement under which Agilent will acquire Multiplicom, a leading European diagnostics company with state-of-the-art genetic testing technology and products.... Read more